Daniel moderated the ‘Biomarkers For Ageing & Age-Related Disorders’ workshop at the Oxford Globals Biomarkers Conference including Nir Barzalai and Bernardo Lemos
Featured in Nathan Cheng’s Clubhouse Longevity Biotech show
Featured in Nathan Cheng’s Mitochondrial Longevity Companies
Finalist at BIOEurope Startup Slam
Daniel interviewed by Careers in Discovery
Daniel interviewed by Lifespan.io
Finalist, AstraZeneca StartUP competition
Daniel interviews Aubrey de Grey at SENS Institute, Mountain View
Accelerate@Babraham 2019 start-up competition winner
Daniel attends XPrize Longevity Workshop also attended by Steve Horvath, Peter Diamandis, Aubrey de Grey and Laura Deming
First in vivo study started with healthy aged mice
First in vivo study started with POLG accelerated aging model
Initial seed funding round completed.
First UK patent application filed.
Company founded by Dr Daniel Ives.
Recent data has shown that mtDNA synthesis precedes endoplasmic reticulum-mediated mitochondrial division (ERMD), suggesting that mtDNA biogenesis plays a role in maintaining mitochondria morphology. ER-mitochondria contact sites may prove to be essential for mtDNA synthesis, and also for lipid and calcium exchange.
Lauren Uchiyama, Aggie Transcript, Biochemistry and Molecular Biology class of 2017, UC Davis
Visit source page